검역본부, '동물용 신약 전담 심사팀'으로 업계 맞춤형 지원 이어나가

<p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">농림축산검역본부</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">(</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">본부장 최정록</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">이하 검역본부</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">)</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">는 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">2024</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">년 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">5</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">월부터 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">'</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">동물용</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">신약 전담 심사팀</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">'</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">을 신설하고</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">재작년에 이어 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">2</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">년 연속으로 동물용 신약 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">7</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">품목을 허가</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;vertical-align:super;font-size:14.0pt;">*</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">하는 등 현장에서 수요가 급증하고 있는 반려동물용 신약 개발을</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">지속적으로 지원하고 있다고 밝혔다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">.</span></p><br><p style="margin: 2pt 0pt 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;"> </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">* </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">최근 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">5</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">년간 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">동물용 신약 허가현황</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">:</span><span style="font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;"> </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">('25) 7</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">건</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">, ('24) 7</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">건</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">, ('23) 1</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">건</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">, ('22) 0</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">건</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.3pt;text-raise:0pt;font-size:12.0pt;">, ('21) 6</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.3pt;font-size:12.0pt;">건</span></p><br><p style="style-name:'바탕글';line-height:160%;margin-left:0pt;margin-right:0pt;text-indent:0pt;margin-top:0pt;margin-bottom:0pt;text-align:justify;word-break:break-hangul;layout-grid-mode:both;vertical-align:baseline;pagination:none;text-autospace:none;padding-alt:0pt 0pt 0pt 0pt;font-family:함초롬바탕;font-family:함초롬바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:10.0pt;color:#000000;font-kerning:0pt; line-height:150%;pagination:none;text-autospace:none;padding-alt:0pt 0pt 0pt 0pt;font-size:14.0pt;color:#0000ff;"> </p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:바탕;letter-spacing:-0.7pt;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.7pt;font-size:14.0pt;">동물용 신약 심사는 항목별</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:14.0pt;">(</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.7pt;font-size:14.0pt;">안전성</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:14.0pt;">·</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.7pt;font-size:14.0pt;">유효성</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:14.0pt;">·</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.7pt;font-size:14.0pt;">기준규격</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:14.0pt;">)</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.7pt;font-size:14.0pt;">로 복합적으로 진행되는데</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">그간 동물약품 업계에서는 심사자료 작성이나 임상시험 설계에 어려움을 </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">겪는 등 시장 진입이 지연되는 경우가 많았다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.4pt;text-raise:0pt;font-size:14.0pt;">. </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">이에 검역본부는 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.4pt;text-raise:0pt;font-size:14.0pt;">'</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">동물용 신약</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">전담 심사팀</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">'</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">을 통해 심사자료 작성 관련 사전 상담</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">임상시험 설계 전략 등 신약 개발 전</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">(</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">全</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">) </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">과정에 대한 맞춤형 컨설팅을 진행하며</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">('25</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">년 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">42</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">회</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">) </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">심사의 전문성을 높이고 업계 지원을 강화해 오고 있다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">.</span></p><br><p style="style-name:'바탕글';line-height:160%;margin-left:0pt;margin-right:0pt;text-indent:0pt;margin-top:0pt;margin-bottom:0pt;text-align:justify;word-break:break-hangul;layout-grid-mode:both;vertical-align:baseline;pagination:none;text-autospace:none;padding-alt:0pt 0pt 0pt 0pt;font-family:함초롬바탕;font-family:함초롬바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:10.0pt;color:#000000;font-kerning:0pt; line-height:150%;pagination:none;text-autospace:none;padding-alt:0pt 0pt 0pt 0pt;font-size:14.0pt;color:#0000ff;"> </p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">특히</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">지난해 허가된 동물용 신약 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">7</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">품목</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;vertical-align:super;font-size:14.0pt;">* </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">중에는 국내 제조사가 개발한 </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">반려견용 심장질환 치료제 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.4pt;text-raise:0pt;font-size:14.0pt;">2</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">종이 포함되어 수입 의존도가 높았던 반려동물용</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">의약품 시장에서 국내 기업의 개발 역량을 입증하였다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.4pt;text-raise:0pt;font-size:14.0pt;">. </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.4pt;font-size:14.0pt;">또한 반려견용 항암제</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">2</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">종</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">(</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">구강흑색종</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">피부비만세포종</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">)</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">에 대해서는 신속 심사</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;vertical-align:super;font-size:14.0pt;">**</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">를 진행하여 희귀질환 치료제의 국내 도입 시기를 앞당기는 등 동물약품 업계에 실질적인 기술지원을 제공하였다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">.</span></p><br><p style="margin: 2pt 0pt 0pt 23.4pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%; text-indent: -23.4pt;"><span style="font-family:맑은 고딕;letter-spacing:-0.2pt;font-size:12.0pt;"> </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.2pt;text-raise:0pt;font-size:12.0pt;">* </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">개</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">(5): </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">항암제 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">2, </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">심장질환 치료제 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">2, </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">기생충약 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">1/</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">고양이</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">(2): </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">고혈압치료제 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">1/</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;letter-spacing:-0.7pt;font-size:12.0pt;">당뇨치료제 </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:-0.7pt;text-raise:0pt;font-size:12.0pt;">1</span></p><br><p style="margin: 0pt 0pt 0pt 23.2pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%; text-indent: -23.2pt;"><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:12.0pt;">** </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-size:12.0pt;">동물의 생명을 위협하는 희귀한 질환이나 긴박한 상황의 경우</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:12.0pt;">, </span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-size:12.0pt;">국내 임상시험 자료 면제 및 일부 독성</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-family:맑은 고딕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:12.0pt;">·</span><span style="font-family:맑은 고딕;font-family:맑은 고딕;font-size:12.0pt;">약리시험 자료 대체 가능</span></p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; line-height: 150%; font-size: 14pt;"> </p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">검역본부는 앞으로도 신약 전담 심사팀을 지속 운영하는 한편</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">수요가 늘고 있는 첨단 바이오의약품과 희귀 난치성 질환 치료제 등 일반 동물용의약품에 비해 상대적으로 심사 기준이 복잡하고 까다로운 고난도 신약에 </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.1pt;font-size:14.0pt;">대한 심사 역량을 강화하고</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.1pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.1pt;font-size:14.0pt;">반려동물용 의약품 맞춤형 안전성</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.1pt;text-raise:0pt;font-size:14.0pt;">·</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.1pt;font-size:14.0pt;">유효성 심사</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">기준을 체계화한 가이드라인을 연내 마련하여 그 제도적 기반도 공고히 할 예정이다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">.</span></p><br><p style="style-name:'바탕글';line-height:160%;margin-left:0pt;margin-right:0pt;text-indent:0pt;margin-top:0pt;margin-bottom:0pt;text-align:justify;word-break:break-hangul;layout-grid-mode:both;vertical-align:baseline;pagination:none;text-autospace:none;padding-alt:0pt 0pt 0pt 0pt;font-family:함초롬바탕;font-family:함초롬바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:10.0pt;color:#000000;font-kerning:0pt; line-height:150%;pagination:none;text-autospace:none;padding-alt:0pt 0pt 0pt 0pt;font-size:14.0pt;color:#ff0000;"> </p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">검역본부 최정록 본부장은 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">"</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;color:#0000ff;">재작년</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">에 이어 </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;color:#0000ff;">작년</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">에도 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">7</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">건의 동물용 신약 허가 성과를 달성한 것은 동물용 신약 전담 심사팀 운영을 통해 업계와 </span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">적극적으로 소통한 결과</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">"</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">라고 하면서</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:-0.6pt;text-raise:0pt;font-size:14.0pt;">, "</span><span style="font-family:바탕;font-family:바탕;letter-spacing:-0.6pt;font-size:14.0pt;">앞으로도 동물약품 업계에 대한 맞춤형</span><span style="font-family:바탕;font-size:14.0pt;"> </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">기술지원을 더욱 강화하여 신약 개발을 활성화하고</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">, </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">반려동물 건강 증진에 기여하겠다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">"</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">라고 말했다</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">.</span></p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; line-height: 150%; font-size: 14pt;"> </p><br><p style="margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt; line-height: 150%;"><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">붙임 </span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">2025</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">년 검역본부 동물용 신약</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">(7</span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">품목</span><span style="font-family:바탕;font-family:바탕;font-family:바탕;font-width:100%;letter-spacing:0pt;text-raise:0pt;font-size:14.0pt;">) </span><span style="font-family:바탕;font-family:바탕;font-size:14.0pt;">허가 현황</span></p><br><p style="line-height: 160%; margin: 0pt; text-indent: 0pt; text-align: justify; vertical-align: baseline; font-family: 함초롬바탕; letter-spacing: 0pt; font-size: 10pt;"> </p><br><div id="hwpEditorBoardContent" class="hwp_editor_board_content" data-hjsonver="1.0" data-jsonlen="28321"> </div>
<p> </p><br>